Premium
Asia healthcare-focussed private equity firm Quadria Capital, which has backed names like Maxivision Eye Hospitals, MediBuddy, Nobel Hygiene and Concord Biotech, is now eyeing a fresh bet in a homegrown dialysis chain, a media report has said citing people aware of the development. The PE firm, managing over $1.5 billion in ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
